Extended spectrum beta lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in diabetic foot infection

Indian Journal of Medical Microbiology

Volumn 26, Issue 3, 2008, Pages 281-282

  Varaiya, A ^a   Dogra, J ^a   Kulkarni, M ^a   Bhalekar, P ^a  

^a SL Raheja Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM; CEFTAZIDIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; CONTROLLED STUDY; DIABETIC FOOT; ESCHERICHIA COLI; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; INDIA; INFECTION; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; LETTER; TERTIARY HEALTH CARE;

EID: 48249088935     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.42056     Document Type: Letter

References (5)

1. nd. ESBLs: Epidemiology, detection and treatment. Pharmacotherapy 2001;21:920-8.
2. Subha A, Ananthan S. Extended Spectrum beta lactamase (ESBL) mediated resistance to third generation cephalosporins among Klebsiella Pneumoniae in Chennai. Indian J Med Microbiol 2002;20:92-5.
3. th ed. CLSI Document M2- A9, Vol. 26 No 1. Wayne PA: 2006.
4. Motta RN, Oliveira MM, Magalhaes PS, Dias AM, Aragao LP, Forti AC, et al. Plasmid mediated extended spectrum beta-lactamase producing strains of Enterobacteriaceae isolated from diabetic foot infections in Brazilian diabetic centre. Braz J Infect Dis 2003;7:129-34.
5. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 2006;29:1727-32.